SMG SCOTTS MIRACLE-GRO CO
Agricultural Chemicals · NYSE · SEC CIK 825542 · Fiscal year ends 09/30
Financial factors as of 2026-06-27 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY1.3%
TTM net income YoY—
TTM EPS YoY48.8%
Revenue 3-yr CAGR-2.8%
Net income 3-yr CAGR—
Margins
Gross margin32.3%
Operating margin11.8%
Net margin2.2%
FCF margin7.8%
EBITDA margin13.7%
Returns
ROE—
ROA2.4%
ROIC (approx.)12.5%
Asset turnover1.08x
Leverage & solvency
Liabilities / assets106.6%
Debt / equity—
Current ratio1.21x
Interest coverage3.53x
Cash quality & payout
Operating cash flow / net income5.00x
Accruals ratio-9.4%
Payout ratio208.9%
Capex / revenue3.1%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | 2026Q32026-06-27 | 2026Q22026-03-28 | 2026Q12025-12-27 | 2025Q4*2025-09-30 | 2025Q32025-06-28 | 2025Q22025-03-29 | 2025Q12024-12-28 | 2024Q4*2024-09-30 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | $1.17B | $1.46B | $354.40M | $387.30M | $1.16B | $1.39B | $366.60M | $414.70M |
| Cost of revenue | $805.00M | $849.00M | $264.40M | $359.60M | $784.60M | $842.30M | $276.70M | $427.30M |
| Gross profit | $365.90M | $610.50M | $88.70M | $23.50M | $372.70M | $542.10M | $88.50M | -$29.50M |
| SG&A expense | $145.60M | $199.20M | $106.00M | $136.90M | $144.80M | $177.80M | $113.50M | $117.60M |
| Operating income | $169.60M | $401.80M | -$21.80M | -$150.10M | $221.80M | $349.70M | -$45.80M | -$216.10M |
| Interest expense | $28.00M | $31.30M | $27.20M | $26.80M | $31.80M | $36.60M | $33.90M | $33.20M |
| Pretax income | $155.20M | $364.90M | -$63.30M | -$207.40M | $214.00M | $306.00M | -$90.90M | -$312.20M |
| Income tax | $51.60M | $101.60M | -$15.50M | -$38.70M | $59.30M | $85.30M | -$24.80M | -$68.20M |
| Net income | $112.20M | $238.60M | -$125.00M | -$151.90M | $149.10M | $217.50M | -$69.50M | — |
| EBITDA | $185.60M | $417.20M | -$6.20M | -$134.50M | $237.30M | $365.50M | -$30.00M | -$184.30M |
| EPS (basic) | 1.93 | 4.11 | -2.16 | — | 2.58 | 3.78 | -1.21 | — |
| EPS (diluted) | 1.90 | 4.04 | -2.16 | — | 2.54 | 3.72 | -1.21 | — |
| Dividends declared per share | 0.66 | 0.66 | 0.66 | 0.66 | 0.66 | 0.66 | 0.66 | 0.66 |
| Weighted avg. shares (diluted) | 59.20M | 59.10M | 57.90M | — | 58.60M | 58.40M | 57.30M | — |
| Balance sheet | ||||||||
| Cash & equivalents | $27.70M | $6.20M | $8.30M | $32.80M | $39.60M | $8.70M | $5.70M | $71.60M |
| Receivables | $713.00M | $766.70M | $193.80M | $160.80M | $545.70M | $767.80M | $173.00M | $176.80M |
| Inventory | $481.40M | $696.00M | $846.70M | $542.70M | $485.40M | $709.60M | $844.90M | $587.50M |
| Current assets | $1.35B | $1.62B | $1.26B | $940.30M | $1.28B | $1.73B | $1.29B | $980.40M |
| PP&E, net | $635.10M | $627.40M | $617.30M | $607.60M | $580.90M | $571.30M | $574.30M | $609.50M |
| Goodwill | $243.90M | $243.90M | $243.90M | $243.90M | $243.90M | $243.90M | $243.90M | $243.90M |
| Intangibles | $350.10M | $350.90M | $351.40M | $352.00M | $352.60M | $353.00M | $353.60M | $418.80M |
| Total assets | $3.17B | $3.41B | $3.03B | $2.74B | $3.09B | $3.54B | $3.17B | $2.87B |
| Current liabilities | $1.11B | $1.28B | $932.40M | $739.70M | $798.60M | $1.01B | $683.80M | $750.30M |
| Short-term debt | $277.00M | $279.40M | $278.30M | $57.20M | $52.10M | $54.60M | $54.60M | $52.60M |
| Long-term debt | $1.84B | $2.07B | $2.25B | $2.05B | $2.14B | $2.49B | $2.64B | $2.17B |
| Total debt | $2.11B | $2.35B | $2.53B | $2.11B | $2.19B | $2.55B | $2.69B | $2.23B |
| Total liabilities | $3.38B | $3.70B | $3.53B | $3.10B | $3.26B | $3.83B | $3.65B | $3.26B |
| Shareholders' equity | -$208.70M | -$286.50M | -$500.60M | -$357.50M | -$170.90M | -$290.10M | -$479.50M | -$390.60M |
| Net debt | $2.09B | $2.34B | $2.52B | $2.07B | $2.15B | $2.54B | $2.69B | $2.16B |
| Shares outstanding | 58.20M | 58.20M | 58.00M | 57.80M | 57.70M | 57.70M | 57.50M | 57.10M |
| Cash flow statement | ||||||||
| Operating cash flow | $345.60M | $220.00M | -$370.40M | $174.10M | $454.40M | $188.10M | -$445.30M | $118.50M |
| Capital expenditure | $24.50M | $18.60M | $20.00M | $42.90M | $16.90M | $8.30M | $29.30M | $16.60M |
| Free cash flow | $321.10M | $201.40M | -$390.40M | $131.20M | $437.50M | $179.80M | -$474.60M | $101.90M |
| Investing cash flow | -$56.70M | -$23.60M | -$21.80M | -$52.10M | -$25.30M | -$11.40M | -$23.30M | -$20.40M |
| Financing cash flow | -$270.00M | -$198.60M | $366.80M | -$135.80M | -$396.10M | -$169.80M | $407.70M | -$306.80M |
| Depreciation & amortization | $16.00M | $15.40M | $15.60M | $15.60M | $15.50M | $15.80M | $15.80M | $31.80M |
| Stock-based compensation | $10.20M | $18.50M | $7.40M | $13.40M | $16.90M | $22.00M | $15.50M | $14.70M |
| Dividends paid | $38.50M | $39.50M | $38.30M | $38.10M | $38.20M | $38.80M | $39.20M | $37.60M |
| Share buybacks | $500,000 | $3.30M | $8.30M | $0 | $100,000 | $2.70M | $15.60M | $100,000 |
Free plan shows the latest 8 periods; Pro shows all 69 🔒
· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.